He is passionate about translational research in Immunology, as well as innovation and disruptive ideas that may help people in need. An immunologist by training, his career is highlighted by several successful entrepreneurial pursuits, including Provention Bio, which he co-founded and where he served as Chief Scientific Officer (acquired by Sanofi in 2023), and Celimmune,…
After leading teams and functions in biopharmaceutical product development in autoimmunity, inflammation, blood disorders, organ transplant rejection and the treatment of acute and chronic viral infections, I’m now charting a new path as an independent consultant leveraging my 25+ years of executive-level strategic experience in the pharma sector. My career has allowed me to serve…
Pepa Lopez Barragan is a trusted expert in regulatory compliance and CMC (Chemistry, Manufacturing, and Controls), bringing a wealth of expertise gained from years of dedicated service at the FDA. Now, as a seasoned regulatory consultant, she leverages her insider knowledge and industry insights to guide pharmaceutical companies through the intricate pathways of product development…
Katja Görnemann is a certified EFFAS financial analyst specialized in Equity and Fixed Income Investor Relations (IR), Corporate Development, Corporate Finance and Corporate Communication. His professional development has focused on the preparation and execution of IPOs (Gestevisión Telecinco, Talgo), corporate bond issuances, as well as the design and implementation of IR strategic plans in multinational…

Former Genentech, Roche, NCI, NIH, DHHS, CEO of American Association for Precision Medicine.

Degree in Biotechnology from the University Pablo de Olavide. CFGS in Web Applications Development.

Degree in Communication and Marketing and expert in communication and marketing strategy, with more than twenty years of professional experience launching companies such as: MSI, ASUS, PNY, KIRRIO.

Degree in Biology from the University of Seville. CFGS in Web Applications Development.







